Association Between Integrin Expression and Prognosis in Localized Prostate Cancer

Autor(es):Mostrar menos -

Pontes-Junior, Jose ^{[1, 2]} ; Reis, Sabrina Thalita ; Neves de Oliveira, Luis Carlos ; Sant'Anna, Alexandre C. ^[2] ; Dall'Oglio, Marcos Francisco ^[2] ; Antunes, Alberto Azoubel ^[2] ; Ribeiro-Filho, Leopoldo Alves ; Carvalho, Paulo Afonso ; Cury, Jose ; Srougi, Miguel ; Moreira Leite, Katia Ramos

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Fac Med, Sch Med, Dept Urol, LIM55, BR-01246903 Sao Paulo - Brazil

^[2] Univ Sao Paulo, Inst Canc Estado Sao Paulo, Sch Med, Dept Urol, BR-01246903 Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: PROSTATE; v. 70, n. 11, p. 1189-1195, AUG 1 2010.
• Citações Web of Science: 23

Resumo

BACKGROUND. Integrins and other adhesion molecules are essential for maintaining the epithelial phenotype. Some studies have reported correlations between abnormalities in their expression and carcinogenesis, but their role in prostate cancer is unclear. Our aim was to study the expression profile of integrins in surgical specimens of prostate cancer and associate their expression patterns with patient outcomes. METHODS. We selected 111 patients with localized prostate cancer who had undergone radical prostatectomy. Of these patients, 60 had no tumor recurrence after a median follow-up of 123 months. Integrin expression was evaluated by immunohistochemistry in a tissue microarray containing two tumor samples per patient. A semiquantitative analysis was employed. We measured the association between the expression of eight integrins and tumor recurrence. RESULTS. Multivariate analysis showed that expression of alpha 3 and alpha 3 beta 1 was related to worse outcome. When alpha 3 expression was strong and alpha 3 beta 1 expression was positive, the odds of recurrence were 3.0- and 2.5-fold higher, respectively. Only 19% and 28% of patients were recurrence-free in a mean period of 123 months of follow up when their tumors showed strong alpha 3 or positive alpha 3 beta 1 immuno-expression, respectively. CONCLUSIONS. We have shown that the expression of integrin alpha 3 beta 1 was independently associated with tumor recurrence after radical prostatectomy, suggesting that this integrin is a potential prognostic marker. Prostate 70: 1189-1195, 2010. (C) 2010 Wiley-Liss, Inc. (AU)

• Processo FAPESP: 06/57373-0 - Estudo dos marcadores moleculares no tumor primario e em metastases osseas e linfonodais de pacientes com cancer de prostata.
• Beneficiário: Kátia Ramos Moreira Leite
• Modalidade de apoio: Auxílio à Pesquisa - Regular